Image
Wear and tear conditions are the leading driver of musculoskeletal-related care and costs in the United States.
The Evernorth Research Institute’s latest cardiodiabesity report helps illustrate sites of care where preventive interventions can make the greatest financial impact.
The landscape of liver disease treatment is evolving rapidly. With new diagnostic tools and promising therapies in development, the future of MASH care is brighter than ever.
Learn how health plans can address LGBTQ+ health disparities and promote inclusive health care practices.
Vaccine hesitancy is increasing cases of a once eliminated disease in the U.S., putting plan sponsors in a unique position to educate and engage their members.